Yesterday I started my review of Abiomed and its unique strategic shift to focus on heart recovery. Despite being the first company with a patented and reimbursed artificial heart, Abiomed altered its focus five years ago. After ...READ»
To assist or replace? That was the question that Mike Minogue focused on during his first few weeks as the new chief executive officer of Abiomed (NASDAQ: ABMD), a technology company that created the first artificial heart. A student ...READ»
